Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Validation of a population coronary disease predictive system: the CASSANDRA model
Kermott, Cindy A. , Bailey, Kent R. , Olson, Janet E.

Journal of Epidemiology and Community Health | May 10, 2014 | Volume: 68 | Issue: 11 | Pages: 1009-1009

10.1136/jech-2014-204165 | PMID 24817707 Get It

HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
Calkins, Hugh , Boehmer, John , Buxton, Alfred E. , Chung, Mina K. , Gold, Michael R. , Hohnloser, Stefan H. , Indik, Julia H. , Mehra, Mandeep R. , Menon, Venu , Page, Richard L. , Shen, Win‐Kuang , Slotwiner, David J. , Stevenson, Lynne W. , Varosy, Paul D. , Welikovitch, Lisa, Kusumoto, Fred M, Indik, Julia, Stevenson, Lynne Warner, Kusumoto, Fred , Lee, Richard Theodore , Shen, Win-Kuang, Mehra, Mandeep R

Circulation | May 9, 2014 | Volume: 130 | Issue: 1 | Pages: 94-125

10.1161/cir.0000000000000056 | PMID 24815500 Get It

Abdominal Aortic Calcium, Coronary Artery Calcium, and Cardiovascular Morbidity and Mortality in the Multi-Ethnic Study of Atherosclerosis
Criqui, Michael H. , Denenberg, Julie O., McClelland, Robyn L. , Allison, Matthew , Guerci, Alan D., Cohoon, Kevin P. , Srikanthan, Preethi , Wong, Nathan D. , Allison, Matthew A, Guerci, Alan, Watson, Karol E., Ix, Joachim H. , Watson, Karol E. , Wong, Nathan , Allison, Matthew A

Arteriosclerosis, Thrombosis, and Vascular Biology | May 9, 2014 | Volume: 34 | Issue: 7 | Pages: 1574-1579

10.1161/atvbaha.114.303268 | PMID 24812323 Get It

Objective— To evaluate the predictive value of abdominal aortic calcium (AAC) for incident cardiovascular disease (CVD) independent of coronary artery calcium (CAC). Approach and Results— We evaluated the association of AAC with CVD in 1974 men and women aged 45 to 84 years randomly selected from the Multi-Ethnic Study of Atherosclerosis participants who had complete AAC and CAC data from computed tomographic scans. AAC and CAC were each divided into following 3 percentile categories: 0 to 50th, 51st to 75th, and 76th to 100th. During a mean of 5.5 years of follow-up, there were 50 hard coronary heart disease events, 83 hard CVD events, 30 fatal CVD events, and 105 total deaths. In multivariable-adjusted Cox models including both AAC and CAC, comparing the fourth quartile with the ≤50th percentile, AAC and CAC were each significantly and independently predictive of hard coronary heart disease and hard CVD, with hazard ratios ranging from 2.4 to 4.4. For CVD mortality, the hazard ratio was highly significant for the fourth quartile of AAC, 5.9 ( P =0.01), whereas the association for the fourth quartile of CAC (hazard ratio, 2.1) was not significant. For total mortality, the fourth quartile hazard ratio for AAC was 2.7 ( P =0.001), and for CAC, it was 1.9, P =0.04. Area under the receiver operating characteristic curve analyses showed improvement for both AAC and CAC separately, although improvement was greater with CAC for hard coronary heart disease and hard CVD, and greater with AAC for CVD mortality and total mortality. Sensitivity analyses defining AAC and CAC as continuous variables mirrored these results. Conclusions— AAC and CAC predicted hard coronary heart disease and hard CVD events independent of one another. Only AAC was independently related to CVD mortality, and AAC showed a stronger association than CAC with total mortality.
Safety and Outcomes of Magnetic Resonance Imaging in Patients with Abandoned Pacemaker and Defibrillator Leads
Higgins, John V., Gard, Joseph J., Espinosa, Raúl E. , Wood, Christopher P. , Felmlee, Joel P. , Cha, Yong‐Mei , Asirvatham, Samuel J. , Dalzell, Connie, Acker, Nancy, Watson, Robert E. , Friedman, Paul A. , Sheldon, Seth H. , Asirvatham, Samuel J

Pacing and Clinical Electrophysiology | May 9, 2014 | Volume: 37 | Issue: 10 | Pages: 1284-1290

10.1111/pace.12419 | PMID 24809591 Get It

IntroductionAbandoned cardiovascular implantable electronic device (CIED) leads remain a contraindication to magnetic resonance imaging (MRI) studies, largely due to in vitro data showing endocardial heating secondary to the radiofrequency field. We tested the hypothesis that abandoned CIED leads do not pose an increased risk of clinical harm for patients undergoing MRI.MethodsThis single‐center retrospective study examined the outcomes of patients who had device generators removed before MRI, rendering the device leads abandoned. Information was gathered through chart review. Data collected included lead model, pacing threshold before MRI, anatomic region examined, threshold data after generator reimplantation, and clinical patient outcome.ResultsPatients (n = 19, 11 men and eight women) ranged in age from 19 to 85 at the time of MRI. There was a mean of 1.63 abandoned leads at the time of imaging; none of the leads were MRI conditional. Of the three implantable cardioverter defibrillator (ICD) leads, two of three were dual coil. Most (31/35) of the scans performed were of the central nervous system, including head and spinal imaging. There were no adverse events associated with MRI in any of these patients with abandoned leads within 7 days of the scan. No lead malfunctions or clinically significant change in pacing thresholds were noted with generator reimplantation.ConclusionThe use of MRI in patients with abandoned cardiac device leads appears feasible when performed under careful monitoring, with no adverse events, although the experience is small. MRI did not affect the function of leads that were subsequently reconnected to a cardiac device.
Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
Martínez‐Bosch, Neus , Fernández‐Barrena, Maite G. , Moreno, Mireia , Ortíz-Zapater, Elena , Munné‐Collado, Jessica, Iglesias, Mar , André, Sabine , Gabius, Hans‐Joachim , Hwang, Rosa F. , Poirier, Françoise, Navas, Carolina, Guerra, Carmen , Fernández-Zapico, Martín E. , Navarro, Pilar , Navarro, Pilar

Cancer Research | May 9, 2014 | Volume: 74 | Issue: 13 | Pages: 3512-3524

10.1158/0008-5472.can-13-3013 | PMID 24812270 Get It

Abstract Despite some advances, pancreatic ductal adenocarcinoma (PDAC) remains generally refractory to current treatments. Desmoplastic stroma, a consistent hallmark of PDAC, has emerged as a major source of therapeutic resistance and thus potentially promising targets for improved treatment. The glycan-binding protein galectin-1 (Gal1) is highly expressed in PDAC stroma, but its roles there have not been studied. Here we report functions and molecular pathways of Gal1 that mediate its oncogenic properties in this setting. Genetic ablation of Gal1 in a mouse model of PDAC (EIa-myc mice) dampened tumor progression by inhibiting proliferation, angiogenesis, desmoplasic reaction and by stimulating a tumor-associated immune response, yielding a 20% increase in relative lifesplan. Cellular analyses in vitro and in vivo suggested these effects were mediated through the tumor microenvironment. Importantly, acinar-to-ductal metaplasia, a crucial step for initiation of PDAC, was found to be regulated by Gal1. Mechanistic investigations revealed that Gal1 promoted Hedgehog pathway signaling in PDAC cells and stromal fibroblasts as well as in Ela-myc tumors. Taken together, our findings establish a function for Gal1 in tumor-stroma crosstalk in PDAC and provide a preclinical rationale for Gal1 targeting as a microenvironment-based therapeutic strategy. Cancer Res; 74(13); 3512–24. ©2014 AACR.
Perplexing Lesions of the Sinonasal Cavity and Skull Base: IgG4‐related and Similar Inflammatory Diseases
Cain, Rachel B. , Colby, Thomas V. , Balan, Vijayan , Patel, Naresh P. , Lal, Devyani , Patel, Naresh P

Otolaryngology–Head and Neck Surgery | May 9, 2014 | Volume: 151 | Issue: 3 | Pages: 496-502

10.1177/0194599814533648 | PMID 24812077 Get It

ObjectiveIgG4‐related disease (IgG4RD) causing sinonasal and skull base pathology is uncommonly described. We present a series of suspected IgG4RD patients, with a pertinent review of the literature to highlight diagnostic challenges.Study DesignCase series.SettingAcademic tertiary care center.Subjects and MethodsCase series of patients with IgG4RD or suspected IgG4RD involving the sinonasal cavity and skull base.ResultsWe present 4 patients with atypical sinonasal and/or skull base disease who were noted to have IgG4‐positive plasma cell infiltration on immunohistochemistry of biopsy specimens. IgG4RD, a recently described entity affecting multiple organs, is characterized by lymphoplasmacytic infiltration and often elevated serum IgG4. IgG4RD can masquerade as malignancy or infection but responds to glucocorticosteroid and immunosuppressant therapy. IgG4RD has been infrequently reported presenting as sinonasal or skull base lesions, and definitive diagnostic criteria for these regions are not established. In our series, IgG4RD was suspected in all 4 patients, but only 1 met all current criteria for definitive diagnosis. All 4 patients, however, responded to corticosteroid therapy, and 1 was placed on long‐term azathioprine.ConclusionIgG4RD is rarely described in the sinonasal cavity and skull base, and specific diagnostic criteria for such disease have not been defined. We present a series of patients with IgG4‐positive plasma cell inflammatory pathology who were suspected to have IgG4RD. Our series highlights diagnostic challenges associated with these patients. Tumefactive and destructive sinonasal‐skull base lesions with a plasma cell‐rich infiltrate should incite suspicion of IgG4RD, and immunohistochemistry for IgG4‐positive plasma cells should be performed.
Usefulness of a Thyroglobulin Liquid Chromatography–Tandem Mass Spectrometry Assay for Evaluation of Suspected Heterophile Interference
Netzel, Brian C., Grebe, Stefan K., Grebe, Stefan K G, Algeciras‐Schimnich, Alicia

Clinical Chemistry | May 9, 2014 | Volume: 60 | Issue: 7 | Pages: 1016-1018

10.1373/clinchem.2014.224816 | PMID 24812415 Get It

Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability
Daams, Marita , Weiler, Florian , Steenwijk, Martijn D. , Hahn, Horst K. , Geurts, Jeroen J.G. , Schijndel, Ronald A. van , Balk, Lisanne J. , Tewarie, Prejaas , Tillema, Jan‐Mendelt , Killestein, Joep , Uitdehaag, Bernard M.J. , Barkhof, Frederik , Vrenken, Hugo , Barkhof, Frederik

Multiple Sclerosis Journal | May 9, 2014 | Volume: 20 | Issue: 14 | Pages: 1860-1865

10.1177/1352458514533399 | PMID 24812042 Get It

Background: The majority of patients with multiple sclerosis (MS) present with spinal cord pathology. Spinal cord atrophy is thought to be a marker of disease severity, but in long-disease duration its relation to brain pathology and clinical disability is largely unknown. Objective: Our aim was to investigate mean upper cervical cord area (MUCCA) in patients with long-standing MS and assess its relation to brain magnetic resonance imaging (MRI) measures and clinical disability. Methods: MUCCA was measured in 196 MS patients and 55 healthy controls using 3DT1-weighted cervical images obtained at 3T MRI. Clinical disability was measured using the Expanded Disability Status Scale (EDSS), Nine-Hole-Peg test (9-HPT), and 25 feet Timed Walk Test (TWT). Stepwise linear regression was performed to assess the association between MUCCA and MRI measures, and between MUCCA and clinical disability. Results: MUCCA was smaller (mean 11.7%) in MS patients compared with healthy controls (72.56±9.82 and 82.24±7.80 mm 2 respectively; p<0.001), most prominently in male patients. MUCCA was associated with normalized brain volume, and number of cervical cord lesions. MUCCA was independently associated with EDSS, TWT, and 9-HPT. Conclusion: MUCCA was reduced in MS patients compared with healthy controls. It provides a relevant marker for clinical disability in long-standing disease, independent of other MRI measures.
Bone Marrow Mononuclear Cell Therapy for Acute Myocardial Infarction
Simari, Robert D., Pepine, Carl J. , Henry, Timothy D. , Spoon, Daniel B., Yeh, ED, Hare, Joshua M. , Schulman, Ivonne Hernandez , Anderson, R. David , Lambert, Charles , Sayre, Shelly L., Taylor, Doris A. , Ebert, Ray F. , Moyé, Lemuel A., Traverse, Jay H. , Bolli, Roberto

Circulation Research | May 8, 2014 | Volume: 114 | Issue: 10 | Pages: 1564-1568

10.1161/circresaha.114.303720 | PMID 24812350 Get It

To understand the role of bone marrow mononuclear cells in the treatment of acute myocardial infarction, this overview offers a retrospective examination of strengths and limitations of 3 contemporaneous trials with attention to critical design features and provides an analysis of the combined data set and implications for future directions in cell therapy for acute myocardial infarction.
Exercise, Hypoglycemia, and Type 1 Diabetes
Basu, Rita , Johnson, Matthew L. , Kudva, Yogish C. , Basu, Ananda

Diabetes Technology & Therapeutics | May 8, 2014 | Volume: 16 | Issue: 6 | Pages: 331-337

10.1089/dia.2014.0097 | PMID 24811269 Get It